Form 8-K

8-K — SPLASH BEVERAGE GROUP, INC.

Accession: 0001731122-26-001047

Filed: 2026-08-12

Period: 2026-08-12

CIK: 0001553788

SIC: 2080 (BEVERAGES)

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — e7845_8-k.htm (Primary)

EX-99.1 — EXHIBIT 99.1 (e7845_ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: e7845_8-k.htm · Sequence: 1

false

0001553788

2026-08-12

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington, D.C.

20549

FORM

8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported):

August 12, 2026

SPLASH

BEVERAGE GROUP, INC.

(Exact name of registrant as specified in its charter)

Nevada

001-40471

34-1720075

(State or other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

1112 N. Flagler Drive

Fort Lauderdale,

Florida

33304

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area

code: (954) 648-7238

Check the appropriate box below if the Form 8-K filing

is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an

emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange

Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark

if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards

provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of

the Act:

Title of Each Class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value

SBEV

NYSE American LLC

Item 7.01 Regulation FD Disclosure

On August 12, 2026, Splash Beverage Group, Inc. (the “Company”)

issued a press release announcing the Company’s name change to Endovia Health Sciences, Inc. A copy of the press release is furnished

as Exhibit 99.1 of this Current Report on Form 8-K.

The information in this Item 7.01 (including Exhibit

99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”)

or otherwise subject to the liabilities under such section, and shall not be deemed to be incorporated by reference into any filing of

the Company under the Securities Act of 1933 or the Exchange Act.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit

Description

99.1

Press Release dated August 12, 2026

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of

the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

SPLASH BEVERAGE GROUP, INC.

Date: August 12, 2026

By:

/s/ Brady Cobb

Name:

Brady Cobb

Title:

Interim Chief Executive Officer

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: e7845_ex99-1.htm · Sequence: 2

EXHIBIT 99.1

Splash Beverage Group to Rebrand as Endovia Health Sciences

New corporate identity reflects Company’s strategic evolution

into a diversified cannabinoid health sciences platform

FORT LAUDERDALE, Fla., August 12, 2026 — Splash Beverage Group,

Inc. (NYSE American: SBEV) (the “Company”) today announced its intention to change its corporate name to Endovia Health

Sciences, Inc., effective August 24, 2026. At that time, the Company will also adopt a new ticker symbol of “EDVA” and

launch EndoviaSciences.com in connection with the rebranding.

The name change reflects the Company’s strategic transformation from

a legacy beverage business into a diversified cannabinoid health sciences platform focused on commercializing pharmaceutical assets, advancing

FDA-regulated human and veterinary therapeutics, and developing innovative cannabinoid wellness and beverage products.

“This is much more than a name change—it is the culmination

of a deliberate strategic transformation,” said Brady Cobb, Interim Chief Executive Officer of the Company.

“Over the past six (6) months, we have methodically repositioned

the Company by acquiring differentiated pharmaceutical intellectual property, establishing international commercialization opportunities,

expanding into FDA-regulated veterinary therapeutics and assembling an experienced cannabinoid pharmaceutical development team. Endovia

Health Sciences reflects both who we are today and the company we intend to become.”

Building a Diversified Cannabinoid Health Sciences Platform

Endovia Health Sciences is being built around three complementary growth

engines designed to create multiple avenues for long-term growth and shareholder value.

Commercial Pharmaceutical Assets

Commercializing differentiated cannabinoid pharmaceutical products through

international distribution, strategic partnerships and licensing opportunities.

FDA-Regulated Human & Veterinary Therapeutics

Advancing proprietary cannabinoid medicines through established regulatory

pathways for both human and companion-animal health.

Consumer Wellness & Beverages

Developing innovative cannabinoid wellness products and beverages as regulations

continue to evolve and new markets emerge.

The Company believes this diversified strategy provides a capital-efficient

approach to building long-term enterprise value while leveraging a common foundation of cannabinoid science, intellectual property and

commercial execution.

Our Vision

To become the global leader in cannabinoid health sciences by developing,

commercializing and advancing innovative therapies and wellness solutions that improve the lives of people and animals around the world.

Our Mission

Endovia Health Sciences acquires, develops and commercializes differentiated

cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Through disciplined capital allocation,

scientific excellence and strategic partnerships, we build scalable businesses that deliver meaningful healthcare innovation and long-term

shareholder value.

“We believe cannabinoids represent one of the most promising frontiers

in modern health sciences,” Cobb continued.

“Our mission is to responsibly unlock that potential through scientific

innovation, strategic partnerships and disciplined execution. Every acquisition, every partnership and every investment we make is intended

to strengthen our position as a leading cannabinoid health sciences company and create lasting value for patients, consumers, partners

and shareholders.”

Looking Ahead

The Company expects the Endovia rebrand to coincide with the launch of

a new corporate website, refreshed investor materials and a unified corporate identity designed to reflect its long-term strategic vision.

As Endovia Health Sciences, the Company intends to continue expanding its

portfolio through strategic acquisitions, commercial partnerships, regulated pharmaceutical development and innovative consumer health

products, all centered on advancing cannabinoid science through disciplined execution.

“Our focus is clear,” Cobb concluded. “Build a science-driven

company with differentiated intellectual property, experienced leadership and multiple pathways to sustainable growth. We believe Endovia

Health Sciences represents the beginning of an exciting new chapter for our shareholders, our partners and the patients and consumers

we ultimately serve.”

About Endovia Health Sciences (Proposed)

Endovia Health Sciences is building a diversified cannabinoid health

sciences platform focused on acquiring, developing and commercializing differentiated cannabinoid health technologies across pharmaceutical,

veterinary and consumer wellness markets.

Where Science Meets Cannabinoid Innovation

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements, including statements

regarding the Company’s rebranding and new strategic focus, efforts towards the development and commercialization of medicinal products

for humans and animals, anticipated trends and expectations for the Company’s business and industry including future growth and

shareholder value, plans to continue expanding its portfolio through strategic acquisitions, commercial partnerships, regulated pharmaceutical

development and innovative consumer health products and other efforts, goals and expectations with respect to the Company’s new

business strategy.

Forward-looking statements involve risks and uncertainties that could cause

actual results to differ materially, including the Company’s ability to raise the necessary capital to finance the its operations

and business plan, satisfy its contractual obligations including our ability to maintain the license under the license agreement for the

CannEpil product on which the Company’s initial focus following its rebranding depends and related agreements in connection therewith,

our ability to complete required studies, establish product safety and efficacy, obtain regulatory authorization, protect intellectual

property and the risk that competitors market the same or similar products, our execute commercialization or strategic-partnering arrangements,

the risk that that the market or demand for any resulting product we seek to commercialize in the future could be less than expected or

projected, our ability to meet our debt obligations and the negative financial and operational consequences of failing to do so, the possibility

that our expectations and perceived benefits with respect to our business plan and strategic transactions we have pursued and may in the

future pursue prove to be incorrect, and risks with respect to our ability to negotiate and execute definitive agreements, satisfy closing

conditions, obtain required approvals with respect to any such strategic transaction. There can be no assurance that the Company’s

goals and milestones will be achieved, that the Company or its collaborators will receive necessary regulatory approvals or that any initiative

will ultimately generate revenue.

Additional risks are described in the Company’s filings with the

Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025 and the Form S-1 filed

on August 7, 2026. The Company undertakes no obligation to update forward-looking statements except as required by law.

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

Aug. 12, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Aug. 12, 2026

Entity File Number

001-40471

Entity Registrant Name

SPLASH

BEVERAGE GROUP, INC.

Entity Central Index Key

0001553788

Entity Tax Identification Number

34-1720075

Entity Incorporation, State or Country Code

Entity Address, Address Line One

1112 N. Flagler Drive

Entity Address, City or Town

Fort Lauderdale

Entity Address, State or Province

Entity Address, Postal Zip Code

33304

City Area Code

(954)

Local Phone Number

648-7238

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, $0.001 par value

Trading Symbol

SBEV

Security Exchange Name

NYSEAMER

Entity Emerging Growth Company

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration